Given the prognostic value of CD8+ T cells in a variety of solid tumors, we then divided the 365 HCC patients into a high activated CD8+ T cell group (CD8Hi, n = 122) and a low activated CD8+ T cell group (CD8Lo, n = 243) based on ssGSEA scores. Here, CD8A is linked to hepatocellular carcinoma.